These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 10957661

  • 41. The fibrinolytic system is not impaired in older men with hypertension.
    DeSouza CA, Dengel DR, Rogers MA, Cox K, Macko RF.
    Hypertension; 1996 May; 27(5):1053-8. PubMed ID: 8621196
    [Abstract] [Full Text] [Related]

  • 42. Effects of intermittent pneumatic compression on venous haemodynamics and fibrinolytic activity.
    Christen Y, Wütschert R, Weimer D, de Moerloose P, Kruithof EK, Bounameaux H.
    Blood Coagul Fibrinolysis; 1997 Apr; 8(3):185-90. PubMed ID: 9167019
    [Abstract] [Full Text] [Related]

  • 43. Deep vein thrombosis and changes in coagulation and fibrinolysis after gynaecological operations in Chinese: the effect of oral contraceptives and malignant disease.
    Tso SC, Wong V, Chan V, Chan TK, Ma HK, Todd D.
    Br J Haematol; 1980 Dec; 46(4):603-12. PubMed ID: 7437338
    [Abstract] [Full Text] [Related]

  • 44. Tissue plasminogen activator and its inhibitor following major surgery in relation to ventilatory pattern.
    Eriksson E, Risberg B.
    Acta Chir Scand; 1988 Jan; 154(1):57-60. PubMed ID: 3128033
    [Abstract] [Full Text] [Related]

  • 45. Fibrinolytic system in adolescents: response to venous occlusion stress tests.
    Monagle P, Chan AK, Albisetti M, Vegh P, Andrew M, Mitchell L.
    Pediatr Res; 2003 Feb; 53(2):333-7. PubMed ID: 12538795
    [Abstract] [Full Text] [Related]

  • 46. Plasminogen activator and plasminogen activator inhibitor I release during experimental endotoxaemia in chimpanzees: effect of interventions in the cytokine and coagulation cascades.
    Biemond BJ, Levi M, Ten Cate H, Van der Poll T, Büller HR, Hack CE, Ten Cate JW.
    Clin Sci (Lond); 1995 May; 88(5):587-94. PubMed ID: 7614818
    [Abstract] [Full Text] [Related]

  • 47. Myocardial injury and systemic fibrinolysis in patients undergoing repair of ruptured abdominal aortic aneurysm: a preliminary report.
    Haggart PC, Adam DJ, Ludman PF, Ludman CA, Bradbury AW.
    Eur J Vasc Endovasc Surg; 2001 Jun; 21(6):529-34. PubMed ID: 11397027
    [Abstract] [Full Text] [Related]

  • 48. Prophylaxis against deep venous thrombosis after total knee arthroplasty. Pneumatic plantar compression and aspirin compared with aspirin alone.
    Westrich GH, Sculco TP.
    J Bone Joint Surg Am; 1996 Jun; 78(6):826-34. PubMed ID: 8666599
    [Abstract] [Full Text] [Related]

  • 49. Endogenous plasminogen activator and venous flow: therapeutic implications.
    Guyton DP, Khayat A, Schreiber H, Husni EA.
    Crit Care Med; 1987 Feb; 15(2):122-5. PubMed ID: 3100134
    [Abstract] [Full Text] [Related]

  • 50. A critical review of the evidence supporting a relationship between impaired fibrinolytic activity and venous thromboembolism.
    Prins MH, Hirsh J.
    Arch Intern Med; 1991 Sep; 151(9):1721-31. PubMed ID: 1888237
    [Abstract] [Full Text] [Related]

  • 51. Effect of optimization of hemodynamics on fibrinolytic activity and antithrombotic efficacy of external pneumatic calf compression.
    Salzman EW, McManama GP, Shapiro AH, Robertson LK, Donovan AS, Blume HW, Sweeney J, Kamm RD, Johnson MC, Black PM.
    Ann Surg; 1987 Nov; 206(5):636-41. PubMed ID: 3314750
    [Abstract] [Full Text] [Related]

  • 52. A randomized, prospective trial of deep venous thrombosis prophylaxis in aortic surgery.
    Killewich LA, Aswad MA, Sandager GP, Lilly MP, Flinn WR.
    Arch Surg; 1997 May; 132(5):499-504. PubMed ID: 9161392
    [Abstract] [Full Text] [Related]

  • 53. [Decreased fibrinolytic capacity in coronary patients by increased plasminogen activator inhibitor activity].
    Ihnken K, Speiser W, Müller-Berghaus G, Beyersdorf F, Schlepper M, Satter P.
    Helv Chir Acta; 1992 Jan; 58(4):503-8. PubMed ID: 1582860
    [Abstract] [Full Text] [Related]

  • 54. Markers of fibrinolysis may predict development of lower extremity arterial disease in patients with diabetes: A longitudinal prospective cohort study with 10 years of follow-up.
    Rautio A, Boman K, Eriksson JW, Svensson MK.
    Diab Vasc Dis Res; 2016 May; 13(3):183-91. PubMed ID: 26818227
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Two different mechanisms in patients with venous thrombosis and defective fibrinolysis: low concentration of plasminogen activator or increased concentration of plasminogen activator inhibitor.
    Nilsson IM, Ljungnér H, Tengborn L.
    Br Med J (Clin Res Ed); 1985 May 18; 290(6480):1453-6. PubMed ID: 3922531
    [Abstract] [Full Text] [Related]

  • 57. Sequential intrapulmonary and systemic activation of coagulation and fibrinolysis during and after total hip replacement surgery.
    Dahl OE, Pedersen T, Kierulf P, Westvik AB, Lund P, Arnesen H, Seljeflot I, Abdelnoor M, Lyberg T.
    Thromb Res; 1993 Jun 15; 70(6):451-8. PubMed ID: 8362370
    [Abstract] [Full Text] [Related]

  • 58. Prospective randomized trial of warfarin and intermittent pneumatic leg compression as prophylaxis for postoperative deep venous thrombosis in major urological surgery.
    Chandhoke PS, Gooding GA, Narayan P.
    J Urol; 1992 Apr 15; 147(4):1056-9. PubMed ID: 1552582
    [Abstract] [Full Text] [Related]

  • 59. [Fibrinolytic activity and tissue plasminogen activator level in healthy individuals prior to and after a ten-minute venous stasis].
    Kubicka A, Libura M, Sacha T, Swadźba J, Undas A, Wandzilak M.
    Pol Tyg Lek; 1992 Apr 15; 48(5-6):116-9. PubMed ID: 8361905
    [Abstract] [Full Text] [Related]

  • 60. Intermittent pneumatic compression prophylaxis for proximal deep venous thrombosis after total hip replacement.
    Woolson ST.
    J Bone Joint Surg Am; 1996 Nov 15; 78(11):1735-40. PubMed ID: 8934490
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.